Barbora Gromova - Publications

Neutrophil-T cell cross talk in noninfectious liver diseases.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: December 01, 2025

Inhibition of estrogen receptor alpha stabilizes regulatory T cell function in autoimmune hepatitis.

Journal: JHEP reports : innovation in hepatology

Published: March 04, 2025

Challenges and insights in detecting early inflammation in DSS-induced colitis using chemiluminescence.

Journal: Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology

Published: January 20, 2025

Therapeutic Effects of DNase I on Peripheral and Local Markers of Liver Injury and Neutrophil Extracellular Traps in a Model of Alcohol-Related Liver Disease.

Journal: International journal of molecular sciences

Published: January 10, 2025

Antisense to human CD39 dysregulates immune metabolism in inflammatory bowel disease.

Journal: Cellular & molecular immunology

Published: October 11, 2024

Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis.

Journal: Journal of autoimmunity

Published: September 28, 2023

Endogenous DNase Activity in an Animal Model of Acute Liver Failure.

Journal: International journal of molecular sciences

Published: November 04, 2022

Sex Difference in Plasma Deoxyribonuclease Activity in Rats.

Journal: Physiological research

Published: October 30, 2021

Fecal Microbiota Transplantation as a Tool for Therapeutic Modulation of Non-gastrointestinal Disorders.

Journal: Frontiers in medicine

Published: April 28, 2021

Extracellular DNA Correlates with Intestinal Inflammation in Chemically Induced Colitis in Mice.

Journal: Cells

Published: November 11, 2020

Nuclear and Mitochondrial Circulating Cell-Free DNA Is Increased in Patients With Inflammatory Bowel Disease in Clinical Remission.

Journal: Frontiers in medicine

Published: August 10, 2020

Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis.

Journal: Journal of hepatology

Published: February 02, 2020